TNF and cholesteryl ester measurement: In the CE-treated aHSCs, both TNF-α and TGH-β1, fibrogenic- and inflammation-associated genes, were significantly reduced by 55% and 45%, respectively, compared to the aHSCs that did not undergo CE treatment.